Days after Paul Simon cancelled two shows in Philadelphia due to “chronic and intense back pain,” the 83-year-old shared a ...

The first atrial septal defects (ASDs) were closed percutaneously in 1974 and reports about their closure published in 1976.1 In the 1980s the Rashkind occluder was introduced and revived the interest ...

Background Young patients suffering from cryptogenic stroke alongside a patent foramen ovale (PFO) are often considered for percutaneous device closure to reduce the risk of stroke recurrence.

Introduction Transcatheter patent foramen ovale (PFO) closure is a safe, effective, and highly successful procedure, associated with a low incidence of in-hospital complications and a low frequency of ...

Major complications such as death, hemorrhage requiring transfusion, cardiac tamponade, need for surgical intervention, and fatal pulmonary embolus occurred in 1.5% of patients whose PFO was closed, ...

Conclusions —Surgical closure of PFO can be performed with minimal morbidity and mortality. PFO closure may decrease the risk of recurrent stroke or TIA and may avoid lifelong anticoagulation in the ...

For adults without a prior PFO-associated stroke: The guidelines recommended against the routine use of PFO closure for the treatment of migraine, for SCUBA divers with prior decompression illness ...